
Heliyon, Journal Year: 2023, Volume and Issue: 9(12), P. e22612 - e22612
Published: Nov. 22, 2023
The Panbio™ COVID-19 IgG Rapid Test Device ("Panbio™") detects antibodies against the SARS-CoV-2 spike protein from viral infection or vaccination.To determine diagnostic sensitivity and specificity of professional use test, using fingerstick whole blood venous plasma.Fingerstick plasma each participant were tested with compared II assay on Abbott Architect™ platform (Europe) equivalent AdviseDx Alinity i™ (US). 447 evaluable participants enrolled across 6 US 9 European clinical centers.For unvaccinated PCR-confirmed ≥21 days post-symptom onset, was 92.6 % (95 CI: 85.9, 96.7), 97.0 93.1, 99.0). For plasma, 90.0 79.5, 96.2) for symptom onset 22-180 ago; 96.3 (92.2, 98.6). vaccinated participants, 98.4 91.2, 100.0) 96.7 88.7, 99.6) plasma.The test had high detecting protein.
Language: Английский